A Look at What Orthofix and SeaSpine Gain from their Merger
The combined Orthofix will have orthopedic sales that approach $700 million for 2022, making it the ninth largest player in the industry. Jan 06, 2023
Orthopedic M&A Transactions Decline Again in 2022
After peaking in 2020, orthopedic M&A volume declined more than 40% in 2021 and dropped another 12% in 2022. Jan 06, 2023
Zimmer Biomet Looks to Rekindle Knee Replacement Growth
While the company remains the dominant player in the knee replacement market, its growth in the segment has plateaued in recent years. Dec 09, 2022
Orthopedic Enabling Technology Remains in Demand Despite Market Pressures
More market entrants and sustained economic pressures have changed the game for hospitals acquiring capital equipment like orthopedic robots. Dec 09, 2022
Orthopedic Executives Remain Bullish on New Tech and ASCs
We round up third-quarter commentary from orthopedic executives as they focus on market expansion, technology, ASCs and staffing. Dec 06, 2022
Orthopedic Market 2022 Projections & 2023 Outlook
The webinar provides 2022 projections for orthopedic market segments and top players as well as expected 2023 market forces. Nov 28, 2022
Medtronic Offsets VBP with Strength in U.S.
The company's orthopedic sales grew in the mid-single-digits for FY 2Q23 on the strength of core spine and enabling technology in the U.S. Nov 28, 2022
ZimVie Sees Substantial Opportunity in Enabling Technology
The company declined in the mid-teens for 3Q22 as it works through its transformation but sees unmet needs that enabling tech could address. Nov 22, 2022
Bioventus Lowers 2022 Guidance, Pauses M&A
The company's 3Q22 orthopedic revenue grew more than 20% but changes to viscosupplement reimbursement will be a headwind through 1H23. Nov 22, 2022
Knee and Hip Replacement Market Recovery Trends
This month’s chart examines the knee and hip replacement sales for the big four players from the beginning of 2019 through 3Q22. Nov 22, 2022
